Bolt Enterprise Value Over E B I T D A from 2010 to 2024
| BOLT Stock | USD 0.76 0.00 0.00% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (0.70) | Current Value (0.73) | Quarterly Volatility 12.37505947 |
Check Bolt Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bolt main balance sheet or income statement drivers, such as Net Interest Income of 6.5 M, Interest Income of 6.5 M or Depreciation And Amortization of 1.8 M, as well as many exotic indicators such as Price To Sales Ratio of 5.11, Dividend Yield of 0.0 or PTB Ratio of 0.39. Bolt financial statements analysis is a perfect complement when working with Bolt Biotherapeutics Valuation or Volatility modules.
Bolt | Enterprise Value Over E B I T D A |
Latest Bolt Biotherapeutics' Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Bolt Biotherapeutics over the last few years. It is Bolt Biotherapeutics' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bolt Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Bolt Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (20.34) | |
| Coefficient Of Variation | (60.85) | |
| Mean Deviation | 10.28 | |
| Median | (25.88) | |
| Standard Deviation | 12.38 | |
| Sample Variance | 153.14 | |
| Range | 35.3822 | |
| R-Value | 0.66 | |
| Mean Square Error | 93.43 | |
| R-Squared | 0.43 | |
| Significance | 0.01 | |
| Slope | 1.82 | |
| Total Sum of Squares | 2,144 |
Bolt Enterprise Value Over E B I T D A History
About Bolt Biotherapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Bolt Biotherapeutics income statement, its balance sheet, and the statement of cash flows. Bolt Biotherapeutics investors use historical funamental indicators, such as Bolt Biotherapeutics's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Bolt Biotherapeutics investors may use each financial statement separately, they are all related. The changes in Bolt Biotherapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bolt Biotherapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bolt Biotherapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bolt Biotherapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (0.70) | (0.73) |
Pair Trading with Bolt Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bolt Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Bolt Stock
| 0.54 | VALN | Valneva SE ADR | PairCorr |
The ability to find closely correlated positions to Bolt Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bolt Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bolt Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bolt Biotherapeutics to buy it.
The correlation of Bolt Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bolt Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bolt Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bolt Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Bolt Biotherapeutics Correlation against competitors. For more information on how to buy Bolt Stock please use our How to Invest in Bolt Biotherapeutics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Bolt Stock analysis
When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Bolt Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bolt Biotherapeutics. If investors know Bolt will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bolt Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.66) | Revenue Per Share 0.299 | Quarterly Revenue Growth 1.888 | Return On Assets (0.27) | Return On Equity (0.48) |
The market value of Bolt Biotherapeutics is measured differently than its book value, which is the value of Bolt that is recorded on the company's balance sheet. Investors also form their own opinion of Bolt Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bolt Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bolt Biotherapeutics' market value can be influenced by many factors that don't directly affect Bolt Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bolt Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bolt Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bolt Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.